From: Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review
Epidemiologic outcomes | Burden outcomes |
---|---|
Prevalence (any timeframe) | Generic quality of life scores measured via the following tools: EQ-5D HUI-1, HUI-2/HUI-3 SF6/SF6D/SF12, SF36 MOS, RAND12 or RAND 36 PedsQL |
Incidence (any timeframe) | Utility values derived from generic preference-based instruments listed above |
Disease natural history—disease progression | Disease-specific quality of life scores measures (any) |
Mortality | Mapping studies, from disease-specific to generic preference-based measures or between different generic preference-based measures |
Disutilities associated with adverse events e.g. pruritus | |
Caregiver utility values | |
Descriptive summary of health states, and/or change in health status/QoL results |